Average Co-Inventor Count = 4.00
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Centre National De La Recherche Scientifique (4 from 5,089 patents)
2. Université De Lausanne (3 from 23 patents)
3. Other (2 from 832,891 patents)
4. Institut National De La Sante Et De La Recherche Medicale (2 from 1,744 patents)
5. Azienda Socio Sanitaria Territoriale Papa Giovanni Xxiii (2 from 2 patents)
6. University of Lausanne (1 from 8 patents)
7. Mablife (1 from 3 patents)
8. Azienda Ospedaliera Papa Giovanni Xxiii (1 from 1 patent)
9. Immune Pharmaceuticals Ltd. (1 from 1 patent)
10. Monoclonal Antibodies Therapeutics (1 from 1 patent)
11. Monoclonal Antibodies Therapeutics “m.a.t.” (1 from 1 patent)
12. Jean Kadouche (1 from 1 patent)
13. University Health Network (291 patents)
14. Kadouche, Jean (0 patent)
8 patents:
1. 12378325 - Multispecific antigens binding fragments and multspecific antibodies
2. 11945879 - Multispecific antigens binding fragments and multispecific antibodies
3. 10815310 - Multispecific antigen binding fragments and multispecific antibodies derived therefrom comprising mutant CH1 and CL-kappa domains
4. 9631031 - Multispecific antigens binding fragments and multispecific antibodies derived therefrom comprising mutant CH1 and CL-κ domains
5. 8728477 - Nucleotide and protein sequences of an antibody directed against an epitope common to human acidic and basic ferritins, monoclonal antibodies or antibody-like molecules comprising these sequences and uses thereof
6. 8409573 - Anti-CD71 monoclonal antibodies and uses thereof for treating malignant tumor cells
7. 7736647 - Anti-CD71 monoclonal antibodies and uses thereof for treating malignant tumor cells
8. 7153506 - Use of anti-ferritin monoclonal antibodies in the treatment of some cancers